Abstract: The present invention provides new addition compounds of guanidinoacetic acid with malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid as well as in the form of sodium, potassium or calcium guanidinoacetate. These addition compounds have improved physiological and therapeutic properties and are particularly suitable for use as dietary supplements, as animal feeds and in cosmetic or dermatological preparations in which especially the marked stability and good bioavailability of the addition compounds come to the fore.

Abstract: The present invention relates to the use of guanidinoacetic acid and/or salts thereof as feed additive, in predominantly vegetarian diets, in particular use being made of salts with hydrochloric acid, hydrobromic acid and phosphoric acid. The use proceeds especially in individual doses from 0.01 to 100 g/kg of feed in the form of powders, granules, pastilles or capsules, the feed additive also being able to be used in combination with other physiologically active materials of value. The claimed use which is suitable especially for breeding and growing livestock, has recourse to a compound which is in particular stable in aqueous solution, can be converted to creatine under physiological conditions, and, in contrast to other guanidine derivatives, is completely available to physiological sectors of use.

Abstract: A new finished feed for domestic pets is proposed, containing at least one guanidinoacetic acid component as the active component with regard to nutritional physiology. The new finished feed which preferably has a water content of >8% by weight, can be produced in an extremely economical manner, wherein the main component has a significantly higher stability during passage through the gastrointestinal tract and is therefore only converted into creative under physiological conditions. For this reason the guanidinoacetic acid is also utilized to a high degree by the target group which is in particular cats and dogs.

Abstract: The present invention provides new addition compounds of guanidinoacetic acid with malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, alpha-ketoglutaric acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid as well as in the form of sodium, potassium or calcium guanidinoacetate. These addition compounds have improved physiological and therapeutic properties and are particularly suitable for use as dietary supplements, as animal feeds and in cosmetic or dermatological preparations in which especially the marked stability and good bioavailability of the addition compounds come to the fore.

Abstract: The present invention describes guanidine derivatives of the general formula (I) having the stated meanings for the residues R1, R2 and R3 as accelerators for cold-curing epoxy resin compositions. The curing of cold-curing epoxy resin systems may advantageously be accelerated with the assistance of these compounds.

Abstract: The invention is directed to an improved, reliably performable process for preparing triallyl isocyanurate (TAIC) by Cu2+-catalysed rearrangement of triallyl cyanurate (TAC) at at least 90° C. According to the invention, TAC and, if required, also a Cu2+ catalyst and solvent are fed continuously to a start reaction mixture after onset of the initially inhibited isomerization reaction, the isomerization is performed at from 90 to 160° C. and an amount of reaction mixture equivalent to the amount of reactant is drawn off continuously and sent to the workup. Preference is given to effecting the isomerization in TAIC as the reaction medium.

Abstract: The present invention provides new salts and/or addition compounds and/or complex compounds of guanidinoacetic acid with malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, ?-ketoglutaric acid, oxalic acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid as well as in the form of sodium, potassium or calcium guanidinoacetate. These salts have improved physiological and therapeutic properties and are particularly suitable for use as dietary supplements, as animal feeds and in cosmetic or dermatological preparations in which especially the marked stability and good bioavailability of the salts come to the fore.

Abstract: The invention relates to a method for the selective catalytic reduction of nitrogen oxides using ammonia in exhaust gases of vehicles, whereby solutions of guanidine salts with an ammonia forming potential of between 40 and 850 g/kg, optionally in combination with urea and/or ammonia and/or ammonium salts, are catalytically decomposed in the presence of catalytically active, non-oxidation-active coatings of oxides selected from the group containing titanium dioxide, aluminum oxide, silicon dioxide or the mixtures thereof, and hydrothermally stable zeolites which are fully or partially metal-exchanged. The guanidine salts according to the invention enable a reduction of the nitrogen oxides by approximately 90%. Furthermore, said guanidine salts can enable an increase in the ammonia forming potential from 0.2 kg, corresponding to prior art, up to 0.4 kg ammonia per litre of guanidine salt, along with freezing resistance (freezing point below ?25° C.).

Abstract: The present invention relates to the use of guanidinoacetic acid and/or salts thereof as feed additive, in predominantly vegetarian diets, in particular use being made of salts with hydrochloric acid, hydrobromic acid and phosphoric acid. The use proceeds especially in individual doses from 0.01 to 100 g/kg of feed in the form of powders, granules, pastilles or capsules, the feed additive also being able to be used in combination with other physiologically active materials of value. The claimed use which is suitable especially for breeding and growing livestock, has recourse to a compound which is in particular stable in aqueous solution, can be converted to creatine under physiological conditions, and, in contrast to other guanidine derivatives, is completely available to physiological sectors of use.

Abstract: The present invention is directed to a process for preparing amides. In particular, the process is directed to a process performable on the industrial scale, in which a ketoxime can be converted to a cyclic or acyclic amide by means of a Beckmann rearrangement using 2,4,6-trichloro-1,3,5-triazine as a catalyst in a nonpolar organic solvent.

Abstract: A free-flowing, powdery composition contains a lipoic acid component and from 0.1 to 25% by weight of the total composition of a silica-based flow aid having a particle size (×100 value) of <800 ?m.

Abstract: The invention relates to the use of aqueous guanidinium formiate solutions, optionally combined with urea and/or ammonia and/or ammonium salts, for the selective catalytic reduction of nitrogen oxides using ammonia in exhaust gases of vehicles. The inventive guanidinium formiate solutions enable a reduction of the nitrogen oxides by approximately 90%. Furthermore, said guanidinium formiate solutions can enable an increase in the ammonia forming potential from 0.2 kg, corresponding to prior art, up to 0.4 kg ammonia per litre of guanidinium formiate, along with freezing resistance (freezing point below ?25° C.). The risk of corrosion of the inventive guanidinium formiate solutions is also significantly reduced compared to that of solutions containing ammonium formiate.

Abstract: Physiological strengthening agents in the form of nutritional supplements, feed additives or in cosmetic preparations in the non-medicinal field of application, as well as plant stimulating agents is the use of guanidine compounds of the general formula (I) or their salts, especially creatinol, creatinol-O-phosphate or one of their salts with aspartic acid, ascorbic acid, succinic acid, fumaric acid, acetic acid or phosphoric acid. R1 and R2 can be organic or inorganic compounds, such as, phosphate, sulfate, acetyl, formyl, methyl, ethyl or propyl. The compounds are as nutritional supplements for, e.g., human being in the fields of education, sports, reconvalescence or geriatrics They can also be used as animal feed additives.

Abstract: The present invention relates to a process for producing postcrosslinked water-absorbing polymeric formations, comprising the steps of contacting water-absorbing polymeric formations P1 obtained by polymerization of ethylenically unsaturated acid-functional monomers or salts thereof in the presence of a crosslinker with a fluid F1 comprising a postcrosslinker, heating the water-absorbing polymeric formations in contact with the fluid F1 to a temperature in a range from 40 to 300° C. to obtain postcrosslinked water-absorbing polymeric formations P2, the water-absorbing polymeric formations P1 having a thermal stability, as determined in accordance with the test method described herein, of less than 3.0%.

Abstract: The use of guanidinoacetic acid and/or salts thereof in combination with choline and/or betaine to produce an agent for improving brain function, bone growth and the mineralization of bones, for improving cartilage growth, for alleviating aging processes, for strengthening the immune system, as an antioxidative and neuroprotective agent, for lowering the cholesterol and triglyceride value, for preventing inflammatory processes and for lowering the blood sugar level in humans and vertebrates is described. In this connection it has surprisingly turned out that the new agents have a considerably higher bioavailability and are thus better taken up into the cells than was previously known when using creatine.

Abstract: The invention relates to a method for the selective catalytic reduction of nitrogen oxides using ammonia in exhaust gases of vehicles, whereby solutions of guanidine salts with an ammonia forming potential of between 40 and 850 g/kg, optionally in combination with urea and/or ammonia and/or ammonium salts, are catalytically decomposed in the presence of catalytically active, non-oxidation-active coatings of oxides selected from the group containing titanium dioxide, aluminum oxide, silicon dioxide or the mixtures thereof, and hydrothermally stable zeolites which are fully or partially metal-exchanged. The guanidine salts according to the invention enable a reduction of the nitrogen oxides by approximately 90%. Furthermore, said guanidine salts can enable an increase in the ammonia forming potential from 0.2 kg, corresponding to prior art, up to 0.4 kg ammonia per litre of guanidine salt, along with freezing resistance (freezing point below ?25° C.).

Abstract: The invention is directed to an improved, reliably performable process for preparing triallyl isocyanurate (TAIC) by Cu2+-catalysed rearrangement of triallyl cyanurate (TAC) at least 90° C. According to the invention, TAC and, if required, also a Cu2+ catalyst and solvent are fed continuously to a start reaction mixture after onset of the initially inhibited isomerization reaction, the isomerization is performed at from 90 to 160° C. and an amount of reaction mixture equivalent to the amount of reactant is drawn off continuously and sent to the workup. Preference is given to effecting the isomerization in TAIC as the reaction medium.

Abstract: The present invention is directed to a process for preparing amides. In particular, the process is directed to a process performable on the industrial scale, in which a ketoxime can be converted to a cyclic or acyclic amide by means of a Beckmann rearrangement using 2,4,6-trichloro-1,3,5-triazine as a catalyst in a nonpolar organic solvent.

Abstract: The invention relates to a method for producing amino- or hydroxybenzonitriles during which, within the scope of an ammonolysis, the corresponding amino- or hydroxybenzoic acid compounds are reacted with ammonia in the presence of a phosphate-containing supported catalyst at temperatures between 250° C. and 500° C. The production step is carried out in a reaction gas without an organic solvent followed by at least a 2-stage purification step.

Abstract: The present invention relates to a liquid formulation for human and animal nutrition, consisting of an aqueous solution, a guanidinoacetic acid component and at least one methyl group donor from the group of choline, methionine and betaine. In addition to the free guanidinoacetic acid, it is also possible to use salts, adducts and/or complexes as the guanidinoacetic acid component, which can additionally be combined with further physiologically active compounds. Since the guanidinoacetic acid component is present in dissolved form, formulations including those in the form of mineral water, lemonade, alcoholic drinks and drinking water formulations are envisaged. It has been found that, surprisingly, the guanidinoacetic acid component present in this liquid formulation has very good stability and is converted very rapidly to creatine in the body.